Elanco Animal Health (ELAN) announced on Friday that two experienced members of its board of directors will not stand for reelection when their tenures conclude this year, reducing the size of its board to nine members.
The veterinary product maker, currently led by an 11-member board, named R. David Hoover and Deborah Kochevar as directors who have decided to step down.
Hoover and Kochevar, who had joined the Elanco (ELAN) board years ago, are expected to conclude their terms at the company’s 2026 annual shareholder meeting scheduled for May.
Hoover had joined as the first chairman of the company’s board in September 2018 at the time of Elanco’s (ELAN) IPO, while Kochevar joined in March 2019 as Elanco (ELAN) completed its spinoff from Eli Lilly (LLY).
